Alfasigma S.p.a.

This study is testing an oral medication called filgotinib in 10 children and teens aged 8 to 17 who have juvenile idiopathic arthritis (JIA). The goal is to see how the drug moves through the body and whether it is safe and tolerable. Participants must have moderately to severel…

This study tests a daily pill called filgotinib in about 80 children aged 8 to 17 with moderate to severe ulcerative colitis. The goal is to see if the drug can safely reduce symptoms and bring the disease under control. Participants take the medicine at home and visit the clinic…

This study looks at the long-term safety and effectiveness of the drug filgotinib in children aged 8 to 17 with juvenile idiopathic arthritis (JIA). Participants must have already completed a prior filgotinib study and shown improvement. The goal is to see if the drug continues t…